Defibrotide in COVID-19 Pneumonia
NCT04335201
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Patients With COVID-19 Pneumonia Will Allow to Detect an Absolute Reduction in the Rate of Respiratory-failure
Interventions
DRUG:
Defibrotide Injection
Sponsor
IRCCS San Raffaele